1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to5
Sponsor: Pharmaceutical / Industry
Protocol IDs: 1839IL/0143, NCT00234429
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor:
Protocol IDs: MRC-CR06, EU-96049, NCT00002893
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-40962, PETACC-1
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: EORTC-08983, NCT00004920
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-6293, E6293
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9519
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NCCTG-935251, NCCTG-93-52-51
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15-75
Sponsor: Pharmaceutical / Industry
Protocol IDs: EORTC-62951
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor:
Protocol IDs: EORTC-08992, NCT00004254
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-93019, NCI-V93-0246
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-146B
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: NCI-93-C-0164, NCI-NMOB-9301
|
|
13.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 12 and under
Sponsor: NCI
Protocol IDs: NCI-93-C-021O, NCI-T93-0109N, T93-0109
|
|
14.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: POG-9379
|
|
15.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95021A4, ZENECA-MSKCC-95021A4, NCI-V96-0987, NCT00002828
|
|
16.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: CAN-NCIC-IND98, NCI-V96-1066, IND98
|
|
17.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UPCC-T96-0063, JMC-T96-0063, NCI-T96-0063O, NCT00002902, T96-0063
|
|
18.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-960104, NCI-T96-0083, T96-0083
|
|
19.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: FCCC-96116, NCI-T96-0113, NCT00003109, T96-0113
|
|
20.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-9779, NCT00003528
|
|
21.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-91-C-177D, NCI-MB-275, NCI-T91-0121N, T91-0121
|
